Anti-vegf therapy and amd: The patient perspective

The patient, SF, 79, was first diagnosed with the "wet" form of age-related macular degeneration (AMD) in 2004. She has since ridden a rollercoaster of emotions, ranging from devastation when a bleed in her left eye destroyed most of the vision there to ecstatic relief when use of intravitreal bevacizumab restored enough vision in the right eye to allow her to regain her driver's license. We interviewed the patient and her doctor, Diana V. Do, MD, Associate Professor of Ophthalmology, Retina Division at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, about the effect of AMD on quality of life.